Cargando…

Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations

BACKGROUND: Glanzmann thrombasthenia (GT) is a rare autosomal recessive abnormality of platelet aggregation with quantitative and/or qualitative abnormality of αIIbβ3 integrin. The αIIbβ3 is a platelet fibrinogen receptor, which is required for platelet aggregation, firm adhesion, and also spreading...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafarghandi Motlagh, F., Fallah, M. S., Bagherian, H., Shirzadeh, T., Ghasri, S., Dabbagh, S., Jamali, M., Salehi, Z., Abiri, M., Zeinali, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487065/
https://www.ncbi.nlm.nih.gov/pubmed/31029159
http://dx.doi.org/10.1186/s13023-019-1042-4
_version_ 1783414433634058240
author Zafarghandi Motlagh, F.
Fallah, M. S.
Bagherian, H.
Shirzadeh, T.
Ghasri, S.
Dabbagh, S.
Jamali, M.
Salehi, Z.
Abiri, M.
Zeinali, S.
author_facet Zafarghandi Motlagh, F.
Fallah, M. S.
Bagherian, H.
Shirzadeh, T.
Ghasri, S.
Dabbagh, S.
Jamali, M.
Salehi, Z.
Abiri, M.
Zeinali, S.
author_sort Zafarghandi Motlagh, F.
collection PubMed
description BACKGROUND: Glanzmann thrombasthenia (GT) is a rare autosomal recessive abnormality of platelet aggregation with quantitative and/or qualitative abnormality of αIIbβ3 integrin. The αIIbβ3 is a platelet fibrinogen receptor, which is required for platelet aggregation, firm adhesion, and also spreading. The disease is more prevalent in the populations with a higher rate of consanguineous marriages as in some Middle Eastern populations including Iraq, Jordan, and Iran. Different types of mutations in ITGA2B and ITGB3 genes have been previously reported to cause the disease. RESULT: In this study, 16 patients with the clinical diagnosis of GT were studied. Direct sequencing of the exons and exon-intron boundaries of the above genes revealed mutations in 14 patients (detection rate: 87.5%). Briefly, out of fifteen types of identified mutations, 14 were novel. Seven mutations in the ITGB3 gene included 4 missense [c.2T > C, c.155 G > T, c. 538 G > A, c.1990 G > T], one nonsense mutation [c.1303 G > T], a small deletion [c.1656_1658delCTC] and a deletion of one nucleotide [c.401delA]. Mutations in the ITGA2B were 8 different mutations consisting 2 missense [c.286 T > A, c.842 C > T], 2 deletions [c.1899 del T, c.189-319_236del], an insertion [c.1071_1072insG] and one splice site mutations [c.409–3 C > G], one synonymous mutation that might alter the normal splicing process [c.1392 A > G] and a nonsense mutation [c.1555 C > T]. The causative mutation in 2 patients remained unknown. Using long-range PCR and sequencing, we found a rather large deletion. The break point of this deletion covers 319 nt from the last part of the first intron and 48 nt from the beginning of the second exon of ITGA2B gene. The deletion was also detected in two unrelated patients with the same ethnicity. In addition, in silico analyses of novel mutations were performed. CONCLUSION: There was no recurrent mutation in the studied population. This may be due to either small sample size or the heterogeneity of the studied population.
format Online
Article
Text
id pubmed-6487065
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64870652019-05-06 Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations Zafarghandi Motlagh, F. Fallah, M. S. Bagherian, H. Shirzadeh, T. Ghasri, S. Dabbagh, S. Jamali, M. Salehi, Z. Abiri, M. Zeinali, S. Orphanet J Rare Dis Research BACKGROUND: Glanzmann thrombasthenia (GT) is a rare autosomal recessive abnormality of platelet aggregation with quantitative and/or qualitative abnormality of αIIbβ3 integrin. The αIIbβ3 is a platelet fibrinogen receptor, which is required for platelet aggregation, firm adhesion, and also spreading. The disease is more prevalent in the populations with a higher rate of consanguineous marriages as in some Middle Eastern populations including Iraq, Jordan, and Iran. Different types of mutations in ITGA2B and ITGB3 genes have been previously reported to cause the disease. RESULT: In this study, 16 patients with the clinical diagnosis of GT were studied. Direct sequencing of the exons and exon-intron boundaries of the above genes revealed mutations in 14 patients (detection rate: 87.5%). Briefly, out of fifteen types of identified mutations, 14 were novel. Seven mutations in the ITGB3 gene included 4 missense [c.2T > C, c.155 G > T, c. 538 G > A, c.1990 G > T], one nonsense mutation [c.1303 G > T], a small deletion [c.1656_1658delCTC] and a deletion of one nucleotide [c.401delA]. Mutations in the ITGA2B were 8 different mutations consisting 2 missense [c.286 T > A, c.842 C > T], 2 deletions [c.1899 del T, c.189-319_236del], an insertion [c.1071_1072insG] and one splice site mutations [c.409–3 C > G], one synonymous mutation that might alter the normal splicing process [c.1392 A > G] and a nonsense mutation [c.1555 C > T]. The causative mutation in 2 patients remained unknown. Using long-range PCR and sequencing, we found a rather large deletion. The break point of this deletion covers 319 nt from the last part of the first intron and 48 nt from the beginning of the second exon of ITGA2B gene. The deletion was also detected in two unrelated patients with the same ethnicity. In addition, in silico analyses of novel mutations were performed. CONCLUSION: There was no recurrent mutation in the studied population. This may be due to either small sample size or the heterogeneity of the studied population. BioMed Central 2019-04-27 /pmc/articles/PMC6487065/ /pubmed/31029159 http://dx.doi.org/10.1186/s13023-019-1042-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zafarghandi Motlagh, F.
Fallah, M. S.
Bagherian, H.
Shirzadeh, T.
Ghasri, S.
Dabbagh, S.
Jamali, M.
Salehi, Z.
Abiri, M.
Zeinali, S.
Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations
title Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations
title_full Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations
title_fullStr Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations
title_full_unstemmed Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations
title_short Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations
title_sort molecular genetic diagnosis of glanzmann syndrome in iranian population; reporting novel and recurrent mutations
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487065/
https://www.ncbi.nlm.nih.gov/pubmed/31029159
http://dx.doi.org/10.1186/s13023-019-1042-4
work_keys_str_mv AT zafarghandimotlaghf moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT fallahms moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT bagherianh moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT shirzadeht moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT ghasris moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT dabbaghs moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT jamalim moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT salehiz moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT abirim moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations
AT zeinalis moleculargeneticdiagnosisofglanzmannsyndromeiniranianpopulationreportingnovelandrecurrentmutations